Skip to main content

MARSHALL WACE, LLP

Position in HROW — Harrow, Inc.

CIK 1318757 LONDON, X0

Position in HROW

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,689,902
-$7,049,905 QoQ
Shares Held
369,435
-42.7% QoQ
Ownership
0.985%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 223 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. HROW ranks #11 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HROW

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,689,902 369,435
2026-03-31 $22,739,807 644,918
2025-12-31 $9,815,043 200,307
2025-09-30 $24,481,028 508,116
2025-06-30 $17,251,312 564,876
2025-03-31 $11,429,328 429,674
2024-06-30 $1,112,371 53,249
2023-12-31 $1,271,580 113,534
2023-09-30 $1,783,690 124,126
2023-03-31 $2,108,149 99,629
2022-12-31 $1,505,962 102,030
2022-09-30 $325,877 26,999
2022-06-30 $189,054 25,969
2021-03-31 $197,586 29,272
2020-03-31 $40,847 10,693